Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression
- PMID: 39436449
- PMCID: PMC11614986
- DOI: 10.1007/s00441-024-03926-2
Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression
Abstract
Hematopoietic stem cells (HSCs) drive cellular turnover in the hematopoietic system by balancing self-renewal and differentiation. In the adult bone marrow (BM), these cells are regulated by a complex cellular microenvironment known as "niche," which involves dynamic interactions between diverse cellular and non-cellular elements. During blood cell maturation, lineage branching is guided by clusters of genes that interact or counteract each other, forming complex networks of lineage-specific transcription factors. Disruptions in these networks can lead to obstacles in differentiation, lineage reprogramming, and ultimately malignant transformation, including acute myeloid leukemia (AML). Zinc Finger Protein 521 (Znf521/Zfp521), a conserved transcription factor enriched in HSCs in both human and murine hematopoiesis, plays a pivotal role in regulating HSC self-renewal and differentiation. Its enforced expression preserves progenitor cell activity, while inhibition promotes differentiation toward the lymphoid and myeloid lineages. Transcriptomic analysis of human AML patient samples has revealed upregulation of ZNF521 in AMLs with the t(9;11) fusion gene MLL-AF9. In vitro studies have shown that ZNF521 collaborates with MLL-AF9 to enhance the growth of transformed leukemic cells, increase colony formation, and activate MLL target genes. Conversely, inhibition of ZNF521 using short-hairpin RNA (shRNA) results in decreased leukemia proliferation, reduced colony formation, and induction of cell cycle arrest in MLL-rearranged AML cell lines. In vivo experiments have demonstrated that mZFP521-deficient mice transduced with MLL-AF9 experience a delay in leukemia development. This review provides an overview of the regulatory network involving ZNF521, which plays a crucial role in controlling both HSC self-renewal and differentiation pathways. Furthermore, we examine the impact of ZNF521 on the leukemic phenotype and consider it a potential marker for MLL-AF9+ AML.
Keywords: Acute myeloid leukemia (AML); Hematopoietic stem cells (HSCs); MLL-AF9 fusion gene; Myeloid and lymphoid differentiation; Transcription factors; Znf521/Zfp521; t (9;11).
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: Not applicable. Informed consent: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.JBJS Essent Surg Tech. 2024 Dec 6;14(4):e23.00094. doi: 10.2106/JBJS.ST.23.00094. eCollection 2024 Oct-Dec. JBJS Essent Surg Tech. 2024. PMID: 39650795 Free PMC article.
-
Single-cell transcriptome profiling of m6A regulator-mediated methylation modification patterns in elderly acute myeloid leukemia patients.Mol Biomed. 2024 Dec 6;5(1):66. doi: 10.1186/s43556-024-00234-7. Mol Biomed. 2024. PMID: 39641872 Free PMC article.
-
Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.Monogr Soc Res Child Dev. 2024 Dec;89(3):7-109. doi: 10.1111/mono.12478. Monogr Soc Res Child Dev. 2024. PMID: 39628288 Free PMC article.
-
Targeting the undruggable: menin inhibitors ante portas.J Cancer Res Clin Oncol. 2023 Sep;149(11):9451-9459. doi: 10.1007/s00432-023-04752-9. Epub 2023 Apr 27. J Cancer Res Clin Oncol. 2023. PMID: 37103568 Review.
References
-
- Abdel-Aziz AK (2023) Advances in acute myeloid leukemia differentiation therapy: a critical review. Biochem Pharmacol 215:115709. 10.1016/J.BCP.2023.115709 - PubMed
-
- Bernaudo F, Monteleone F, Mesuraca M et al (2015) Validation of a novel shotgun proteomic workflow for the discovery of protein-protein interactions: focus on ZNF521. J Proteome Res 14:1888–1899. 10.1021/PR501288H - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical